Check the time stamp on this data. Updated AI-Generated Signals for Humacyte Inc. (HUMA) available here: HUMA.

TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The ...

Piper Sandler analyst Allison Bratzel maintained a Hold rating on Humacyte (HUMA – Research Report) today and set a price target of ...

Humacyte Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 0.00% with a gross margin of 86.22%. The profit margin, also known as the ...

Humacyte, Inc. (HUMA) closed at $5.70 in the latest trading session, marking a +0.53% move from the prior day.

Principal photography concluded in early September, with the film currently in post-production under editor A. Sreekar Prasad ...

Vicky Kaushal will star as Chhatrapati Sambhaji in the historical epic 'Chhaava', causing Maddock Films to delay the release ...

London-based scaleup Huma announced today the expansion of its digital healthcare solutions with the acquisition of eConsult.

Huma Qureshi stars in 'Bayaan', a police drama set in Rajasthan, directed by Bikas Ranjan Mishra. The film, centering on a ...

Huma Qureshi, who is all set to appear in her next film 'Gulabi' gave fans an exciting update by announcing that the movie's ...

On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $5.73 which represents a slight increase of $0.18 or 3.24% from the prior close of $5.55. The stock opened at $5.49 and ...

Huma Qureshi wraps up the shoot for Director Vipul Mehta's Gulabi, starring Parambrata Chattopadhyay, Dibyendu Bhattacharya ...